I-AACC2022

Indawo yeBooth763 

eChicago26-28NgoJulayi 2022

JI-OINSTAR BIOMEDICAL TECHNOLOGYCO.LTD., siyakuvuyela ukwazisa ngokuthatha kwethu inxaxheba kwiI-AACCUmboniso eChicago kulo nyaka.

Singavuya ukudibana nawe kwindawo yethu Ukuba uceba ukuya kumboniso walo nyaka.

JOINSTARisomnye wabavelisi abaphambili bePoint-of-Care e-China kunye novavanyo olungaphezulu kwama-25 olusekwe kwitekhnoloji yokuvavanya iDry Immunofluorescence.Ipotifoliyo yethu yemveliso ebanzi igubungela iindawo zezifo ezifana Iisifo sosulelos, Intliziyo, Isifo sezintso, impilo yokuzala njl. I-Joinstar ihamba phambili ekulawuleni i-Sepsis kunye nokufumaneka kovavanyo lwe-POCT lwenoveli ye-biomarker enelungelo lobunikazi, i-Heparin Binding Protein (HBP).Le noveli biomarker ibonakaliswe njengesalathisi esingcono kwi-sepsis xa kuthelekiswa novavanyo lwesiqhelo lwangoku.Ukongeza kwi-HBP, i-Joinstar yinkampani kuphela yokubandakanya iphaneli ye-Sepsis epheleleyo kwi-repertoire yayo, kuquka iimvavanyo ze-PCT kunye ne-IL-6.Ngexesha lobhubhani we-Covid 19 wamva nje ezi mvavanyo, ngakumbi i-HBP, zibonakaliswe njengezona ziphambili kulawulo lwezifo kunye nedatha yakutsha nje evela kupapasho oluninzi lubonisa ukubaI-HBP inokuqikelela ukusilela kokuphefumla kunye nokufa kweentsuku ezingama-28 kwizigulana ze-COVID-19kwaye kunjaloanumngcipheko ozimeleyo wokufa)   

Ngolwazi olongezelelweyo, nceda uqhagamshelaneusngqo okanye undwendwele iwebhusayithi yethu: https://www.joinstar.com/jet-istar-platform/

ngolwazi loqhagamshelwano, ncedaimeyile ku:info@joinstar.cn-wNdijonge phambili ukuva kuwe, kwaye ngethemba lokukubona eChicago!Yiza uzosibona, kwindawo yeJoinstar booth#763kwaye ufunde konke malunga noluhlu lwethu olunomdla lweemveliso kunye nezixhobo.